> 0 1 0 1 O
= 1 2 1 2 O
10 3 5 3 5 B-lower_bound
% 5 6 5 6 I-lower_bound
blasts 7 13 7 13 O
in 14 16 14 16 O
marrow 17 23 17 23 O
or 24 26 24 26 O
blood 27 32 27 32 O

AML 0 3 33 36 B-cancer
other 4 9 37 42 O
than 10 14 43 47 O
acute 15 20 48 53 B-cancer
promyelocytic 21 34 54 67 I-cancer
leukemia 35 43 68 76 I-cancer
( 44 45 77 78 I-cancer
APL 45 48 78 81 I-cancer
) 48 49 81 82 I-cancer
with 50 54 83 87 O
t(15;17)(q22;q12 55 71 88 104 B-clinical_variable
) 71 72 104 105 I-clinical_variable
or 73 75 106 108 O
variants 76 84 109 117 O
according 85 94 118 127 O
to 95 97 128 130 O
the 98 101 131 134 O
2008 102 106 135 139 O
World 107 112 140 145 O
Health 113 119 146 152 O
Organization 120 132 153 165 O
( 133 134 166 167 O
WHO 134 137 167 170 O
) 137 138 170 171 O
classification 139 153 172 186 O
; 153 154 186 187 O
patients 155 163 188 196 O
with 164 168 197 201 O
biphenotypic 169 181 202 214 B-cancer
AML 182 185 215 218 I-cancer

Active 0 6 219 225 O
systemic 7 15 226 234 B-chronic_disease
fungal 16 22 235 241 I-chronic_disease
, 22 23 241 242 O
bacterial 24 33 243 252 O
, 33 34 252 253 O
viral 35 40 254 259 O
, 40 41 259 260 O
or 42 44 261 263 O
other 45 50 264 269 O
infection 51 60 270 279 O
, 60 61 279 280 O
unless 62 68 281 287 O
disease 69 76 288 295 O
is 77 79 296 298 O
under 80 85 299 304 O
treatment 86 95 305 314 B-treatment
with 96 100 315 319 O
anti 101 105 320 324 O
- 105 106 324 325 O
microbials 106 116 325 335 O
and/or 117 123 336 342 O
controlled 124 134 343 353 O
or 135 137 354 356 O
stable 138 144 357 363 O
( 145 146 364 365 O
e.g. 146 150 365 369 O
if 151 153 370 372 O
specific 154 162 373 381 O
, 162 163 381 382 O
effective 164 173 383 392 O
therapy 174 181 393 400 O
is 182 184 401 403 O
not 185 188 404 407 O
available 189 198 408 417 O
/ 198 199 417 418 O
feasible 199 207 418 426 O
or 208 210 427 429 O
desired 211 218 430 437 O
[ 219 220 438 439 O
e.g. 220 224 439 443 O
chronic 225 232 444 451 B-chronic_disease
viral 233 238 452 457 I-chronic_disease
hepatitis 239 248 458 467 I-chronic_disease
, 248 249 467 468 O
human 250 255 469 474 B-chronic_disease
immunodeficiency 256 272 475 491 I-chronic_disease
virus 273 278 492 497 I-chronic_disease
( 279 280 498 499 I-chronic_disease
HIV 280 283 499 502 I-chronic_disease
) 283 284 502 503 I-chronic_disease
] 284 285 503 504 O
) 285 286 504 505 O

Bilirubin 0 9 506 515 B-clinical_variable
= 10 11 516 517 O
< 11 12 517 518 O
2 13 14 519 520 B-upper_bound
times 15 20 521 526 I-upper_bound
institutional 21 34 527 540 I-upper_bound
upper 35 40 541 546 I-upper_bound
limit 41 46 547 552 I-upper_bound
of 47 49 553 555 I-upper_bound
normal 50 56 556 562 I-upper_bound
unless 57 63 563 569 O
elevation 64 73 570 579 O
is 74 76 580 582 O
thought 77 84 583 590 O
to 85 87 591 593 O
be 88 90 594 596 O
due 91 94 597 600 O
to 95 97 601 603 O
hepatic 98 105 604 611 O
infiltration 106 118 612 624 O
by 119 121 625 627 O
AML 122 125 628 631 B-cancer
, 125 126 631 632 O
Gilbert 127 134 633 640 B-chronic_disease
's 134 136 640 642 I-chronic_disease
syndrome 137 145 643 651 I-chronic_disease
, 145 146 651 652 O
or 147 149 653 655 O
hemolysis 150 159 656 665 B-chronic_disease
( 160 161 666 667 O
assessed 161 169 667 675 O
within 170 176 676 682 O
10 177 179 683 685 B-upper_bound
days 180 184 686 690 I-upper_bound
prior 185 190 691 696 I-upper_bound
to 191 193 697 699 O
study 194 199 700 705 O
day 200 203 706 709 O
0 204 205 710 711 O
) 205 206 711 712 O

Concomitant 0 11 713 724 B-chronic_disease
illness 12 19 725 732 I-chronic_disease
associated 20 30 733 743 O
with 31 35 744 748 O
a 36 37 749 750 O
likely 38 44 751 757 O
survival 45 53 758 766 O
of 54 56 767 769 O
< 57 58 770 771 O
1 59 60 772 773 B-upper_bound
year 61 65 774 778 I-upper_bound

Pregnancy 0 9 779 788 B-pregnancy

The 0 3 789 792 O
use 4 7 793 796 O
of 8 10 797 799 O
hydroxyurea 11 22 800 811 B-treatment
prior 23 28 812 817 O
to 29 31 818 820 O
study 32 37 821 826 O
registration 38 50 827 839 O

Women 0 5 840 845 B-gender
of 6 8 846 848 O
childbearing 9 21 849 861 O
potential 22 31 862 871 O
and 32 35 872 875 O
men 36 39 876 879 O
must 40 44 880 884 O
agree 45 50 885 890 B-contraception_consent
to 51 53 891 893 I-contraception_consent
use 54 57 894 897 I-contraception_consent
adequate 58 66 898 906 I-contraception_consent
contraception 67 80 907 920 I-contraception_consent
beginning 81 90 921 930 O
at 91 93 931 933 O
the 94 97 934 937 O
signing 98 105 938 945 O
of 106 108 946 948 O
the 109 112 949 952 O
consent 113 120 953 960 O
until 121 126 961 966 O
at 127 129 967 969 O
least 130 135 970 975 O
3 136 137 976 977 B-lower_bound
months 138 144 978 984 I-lower_bound
after 145 150 985 990 O
the 151 154 991 994 O
last 155 159 995 999 O
dose 160 164 1000 1004 O
of 165 167 1005 1007 O
study 168 173 1008 1013 O
drug 174 178 1014 1018 O

high 0 4 1019 1023 O
- 4 5 1023 1024 O
risk 5 9 1024 1028 O
myeloproliferative 10 28 1029 1047 B-cancer
neoplasm 29 37 1048 1056 I-cancer

patient 0 7 1057 1064 O
needs 8 13 1065 1070 O
to 14 16 1071 1073 O
be 17 19 1074 1076 O
clinically 20 30 1077 1087 O
stable 31 37 1088 1094 O
as 38 40 1095 1097 O
defined 41 48 1098 1105 O
as 49 51 1106 1108 O
being 52 57 1109 1114 O
afebrile 58 66 1115 1123 O
and 67 70 1124 1127 O
hemodynamically 71 86 1128 1143 O
stable 87 93 1144 1150 O
for 94 97 1151 1154 O
24 98 100 1155 1157 B-lower_bound
- 100 101 1157 1158 O
48 101 103 1158 1160 B-upper_bound
hours 104 109 1161 1166 I-upper_bound
prior 110 115 1167 1172 I-upper_bound
to 116 118 1173 1175 O
study 119 124 1176 1181 O
day 125 128 1182 1185 O
0 129 130 1186 1187 O
, 130 131 1187 1188 O
unless 132 138 1189 1195 O
fever 139 144 1196 1201 O
is 145 147 1202 1204 O
thought 148 155 1205 1212 O
to 156 158 1213 1215 O
be 159 161 1216 1218 O
secondary 162 171 1219 1228 O
to 172 174 1229 1231 O
the 175 178 1232 1235 O
underlying 179 189 1236 1246 O
hematologic 190 201 1247 1258 B-chronic_disease
disease 202 209 1259 1266 I-chronic_disease

sorafenib 0 9 1267 1276 B-treatment

such 0 4 1277 1281 O
high 5 9 1282 1286 O
- 9 10 1286 1287 O
risk 10 14 1287 1291 O
MDS 15 18 1292 1295 B-chronic_disease
or 19 21 1296 1298 O
MPN 22 25 1299 1302 B-chronic_disease
have 26 30 1303 1307 O
natural 31 38 1308 1315 O
history 39 46 1316 1323 O
much 47 51 1324 1328 O
closer 52 58 1329 1335 O
to 59 61 1336 1338 O
AML 62 65 1339 1342 B-cancer
than 66 70 1343 1347 O
to 71 73 1348 1350 O
lower 74 79 1351 1356 O
risk 80 84 1357 1361 O
MDS 85 88 1362 1365 O
or 89 91 1366 1368 O
MPN 92 95 1369 1372 O
and 96 99 1373 1376 O
have 100 104 1377 1381 O
responded 105 114 1382 1391 O
similarly 115 124 1392 1401 O
to 125 127 1402 1404 O
AML 128 131 1405 1408 B-treatment
- 131 132 1408 1409 I-treatment
type 132 136 1409 1413 I-treatment
therapy 137 144 1414 1421 I-treatment

